Nanjing Delova Biotech Co., Ltd. ("Delova") today announced positive results from two pivotal Phase 3 clinical trials ...

Partnership marks a major validation of AmacaThera's scalable hydrogel delivery technology and its transformative potential across multiple therapeutic areas AmacaThera's innovative hydrogel-based ...

Glenmark Pharmaceuticals Inc., USA, has announced the upcoming launch of Ropivacaine Hydrochloride Injection USP in three concentrations — 40 mg/20 mL (2 mg/mL), 150 mg/30 mL (5 mg/mL), and 200 mg/20 ...

Shares of Glenmark Pharmaceuticals Ltd. gained on Thursday, October 23, after the company said its US subsidiary, Glenmark Pharmaceuticals Inc., is set to launch Ropivacaine Hydrochloride Injection ...

The FDA issued a warning letter to Amneal Pharmaceuticals criticizing the drugmaker for failing to correct problems that led to a string of recalls of its generic vancomycin and ropivacaine ...

The FDA has issued a warning letter to Amneal Pharmaceuticals, citing “significant violations” of manufacturing standards after finding the drugmaker used contaminated IV bags in the manufacture of ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Ropivacaine safe and effective alternative to lidocaine for local anaesthesia in orthognathic procedures suggests a new study published in the Inflammopharmacology. This triple-blind, controlled ...

The Food and Drug Administration published a notice from Amneal Pharmaceutical that said the company is recalling two lots of its Ropivacaine Hydrochloride Injection 500mg/100mL Infusion bags due to ...

The recalled products include Lot #AL240003 (exp. 01/26) and Lot #AL240004 (exp. 01/26). Amneal Pharmaceuticals is recalling 2 lots of Ropivacaine Hydrochloride (HCl) Injection, USP, 500mg/100mL ...